Intravenous misuse of slow-release oral morphine capsules: how much morphine is injected?

被引:3
作者
Bertin, Celian [1 ,2 ,3 ]
Montigne, Edouard [1 ]
Teixeira, Sarah [1 ]
Ferrer, Florent [1 ]
Lauwerie, Louis [1 ]
Richard, Damien [1 ]
Authier, Nicolas [1 ,2 ,3 ]
机构
[1] Univ Clermont Auvergne, CHU Clermont Ferrand, Ctr Addictovigilance & Pharmacovigilance, Ctr Evaluat & Traitement Douleur,Inserm 1107 Neuro, F-63003 Clermont Ferrand, France
[2] Univ Clermont Auvergne, Observ Francais Medicaments Antalg OFMA, CHU Clermont Ferrand, French Monitoring Ctr Analges Drugs, F-63001 Clermont Ferrand, France
[3] Fdn Inst Analgesia, UFR Med & Profess Paramed, F-63001 Clermont Ferrand, France
关键词
Person who inject drugs; Morphine; Opioid use disorder; Misuse; Harm reduction; SULFATE ABUSE; DRUG-ABUSE; SUBSTITUTION; DEPENDENCE;
D O I
10.1186/s12954-023-00781-2
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
BackgroundThe injection of morphine from morphine sulfate capsules containing sustained-release microbeads (Skenan (R)) is a practice frequently described by French intravenous opioid users. They seek an injectable form of substitution for heroin. Depending on how the syringe is prepared, the morphine rates may vary. The dosage of the capsule, the temperature of the dissolving water and the type of filter used have been identified as the parameters most likely to influence the final quantity of morphine in solution before intravenous injection. The aim of our study was to determine the amounts of morphine actually injected, according to the different preparation modalities described by people who inject morphine and the harm reduction equipment made available to them.MethodsDifferent morphine syringes were prepared by varying the dosage of the capsule (100 or 200 mg), the temperature of the dissolving water before adding morphine, ambient (approximate to 22 degrees C) or heat (approximate to 80 degrees C) and four filtration devices: risk reduction Steribox (R) cotton, risk reduction filter "Sterifilt (R)", "Wheel" filter and cigarette filter. The quantification of the morphine in the syringe body was carried out by liquid phase chromatography coupled with a mass spectrometry detector.ResultsThe best extraction yields were obtained with heated water, independently of dosages (p < 0.01). Yields of 100 mg capsules varied according to the filter (p < 0.01) and the water temperature (p < 0.01), with maximum yields obtained for solutions dissolved in heated water, then filtered with the "Wheel" filter (83 mg). The yields of the 200 mg capsules varied according to the temperature of the water (p < 0.01), without difference according to the filter used (p > 0.01), and maximum yields obtained for solutions dissolved in heated water (95 mg).ConclusionsNo procedure for dissolving Skenan (R) led to the complete dissolution of the morphine it contains. Whatever the variations in preparation conditions, the extraction rates of the 200 mg morphine capsules were lower than those of 100 mg, without the risk reduction filters adversely impacting morphine extraction. Offering an injectable substitution to persons who inject morphine would make it possible to reduce the risks and damage, particularly overdoses, associated with variations in dosage due to preparation methods.
引用
收藏
页数:8
相关论文
共 40 条
[11]   The health consequences of injecting tablet preparations: foreign body pulmonary embolization and pulmonary hypertension among deceased injecting drug users [J].
Darke, Shane ;
Duflou, Johan ;
Torok, Michelle .
ADDICTION, 2015, 110 (07) :1144-1151
[12]   Global patterns of opioid use and dependence: harms to populations, interventions, and future action [J].
Degenhardt, Louisa ;
Grebely, Jason ;
Stone, Jack ;
Hickman, Matthew ;
Vickerman, Peter ;
Marshall, Brandon D. L. ;
Bruneau, Julie ;
Altice, Frederick L. ;
Henderson, Graeme ;
Rahimi-Movaghar, Afarin ;
Larney, Sarah .
LANCET, 2019, 394 (10208) :1560-1579
[13]  
European Monitoring Centre for Drugs and Drug Addiction, 2012, New heroin-assisted treatment-recent evidence and current practices of supervised injectable heroin treatment in Europe and beyond: EMCDDA Insights, DOI [10.2810/50141, DOI 10.2810/50141]
[14]   Surveillance system on drug abuse: Interest of the French national OPPIDUM program of French addictovigilance network [J].
Frauger, Elisabeth ;
Pochard, Liselotte ;
Boucherie, Quentin ;
Giocanti, Adeline ;
Chevallier, Cecile ;
Daveluy, Amelie ;
Gibaja, Valerie ;
Caous, Anne-Sylvie ;
Eiden, Celine ;
Authier, Nicolas ;
Le Boisselier, Reynald ;
Guerlais, Marylene ;
Jouanjus, Emilie ;
Lepelley, Marion ;
Pizzoglio, Veronique ;
Pain, Stephanie ;
Richard, Nathalie ;
Micallef, Joelle .
THERAPIE, 2017, 72 (04) :491-501
[15]   A prospective cohort study on orally administered heroin substitution for severely addicted opioid users [J].
Frick, Ulrich ;
Rehm, Juergen ;
Kovacic, Susanne ;
Ammann, Jeannine ;
Uchtenhagen, Ambros .
ADDICTION, 2006, 101 (11) :1631-1639
[16]   Long-Term Follow-Up of Orally Administered Diacetylmorphine Substitution Treatment [J].
Frick, Ulrich ;
Rehm, Juergen ;
Zullino, Daniele ;
Fernando, Manrique ;
Wiesbeck, Gerhard ;
Ammann, Jeannine ;
Uchtenhagen, Ambros .
EUROPEAN ADDICTION RESEARCH, 2010, 16 (03) :131-138
[17]   Heroin-assisted treatment for opioid dependence - Randomised controlled trial [J].
Haasen, Christian ;
Verthein, Uwe ;
Degkwitz, Peter ;
Berger, Juergen ;
Krausz, Michael ;
Naber, Dieter .
BRITISH JOURNAL OF PSYCHIATRY, 2007, 191 :55-62
[18]  
Haute Autorite de Sante, 2022, BON USAGE MED OPIOID
[19]   Medical prescriptions falsified by the patients: a 12-year national monitoring to assess prescription drug diversion [J].
Jouanjus, Emilie ;
Guernec, Gregory ;
Lapeyre-Mestre, Maryse .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 (03) :306-322
[20]   Siganl Identification in Addictovigilance: the Functioning of the French System [J].
Jouanjus, Emilie ;
Gibaja, Valerie ;
Kahn, Jean-Pierre ;
Haramburu, Francoise ;
Daveluy, Amelie .
THERAPIE, 2015, 70 (02) :123-131